Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease

BMC Systems Biology

Volumn 5, Issue , 2011, Pages

  Pandey, Priyanka ^a   Qin, Shan ^a   Ho, Jacqueline ^b   Zhou, Jing ^c   Kreidberg, Jordan A ^a,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

MICRORNA;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; DIABETIC NEPHROPATHY; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; KIDNEY POLYCYSTIC DISEASE; METABOLISM; METHODOLOGY; MOUSE; MUTATION; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSGENIC MOUSE;

ANIMALS; DIABETIC NEPHROPATHIES; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICE; MICE, TRANSGENIC; MICRORNAS; MODELS, BIOLOGICAL; MODELS, GENETIC; MUTATION; POLYCYSTIC KIDNEY DISEASES; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSCRIPTION, GENETIC;

EID: 79955012441     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-5-56     Document Type: Article

References (70)

1. Torres VE, Harris PC. Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities. J Intern Med 2007, 261(1):17-31. 10.1111/j.1365-2796.2006.01743.x, 17222165.
2. Wilson PD, Goilav B. Cystic disease of the kidney. Annu Rev Pathol 2007, 2:341-368. 10.1146/annurev.pathol.2.010506.091850, 18039103.
3. Wilson PD. Polycystic kidney disease. N Engl J Med 2004, 350(2):151-164. 10.1056/NEJMra022161, 14711914.
4. Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ, Leonhard WN, van de Wal A, Ward CJ, Verbeek S, DeRuiter MC, Breuning MH, de Heer E, et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Human Molecular Genetics 2004, 13(24):3069-3077. 10.1093/hmg/ddh336, 15496422.
5. Chang MY, Parker E, Ibrahim S, Shortland JR, Nahas ME, Haylor JL, Ong AC. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol Dial Transplant 2006, 21(8):2078-2084. 10.1093/ndt/gfl150, 16720597.
6. Hanaoka K, Guggino WB. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 2000, 11(7):1179-1187.
7. Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Cowley BD, Pelling JC, Grantham JJ. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 2003, 63(6):1983-1994. 10.1046/j.1523-1755.2003.00023.x, 12753285.
8. Kim E, Arnould T, Sellin L, Benzing T, Comella N, Kocher O, Tsiokas L, Sukhatme VP, Walz G. Interaction between RGS7 and polycystin. Proc Natl Acad Sci USA 1999, 96(11):6371-6376. 10.1073/pnas.96.11.6371, 26888, 10339594.
9. Kim E, Arnould T, Sellin LK, Benzing T, Fan MJ, Gruning W, Sokol SY, Drummond I, Walz G. The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem 1999, 274(8):4947-4953. 10.1074/jbc.274.8.4947, 9988738.
10. Delmas P, Nomura H, Li X, Lakkis M, Luo Y, Segal Y, Fernandez-Fernandez JM, Harris P, Frischauf AM, Brown DA, et al. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J Biol Chem 2002, 277(13):11276-11283. 10.1074/jbc.M110483200, 11786542.
11. Parnell SC, Magenheimer BS, Maser RL, Zien CA, Frischauf AM, Calvet JP. Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J Biol Chem 2002, 277(22):19566-19572. 10.1074/jbc.M201875200, 11912216.
12. Bhunia AK, Piontek K, Boletta A, Liu L, Qian F, Xu PN, Germino FJ, Germino GG. PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 2002, 109(2):157-168. 10.1016/S0092-8674(02)00716-X, 12007403.
13. Bartel DP. MicroRNAs: Target Recognition and Regulatory Functions. Cell 2009, 136(2):215-233. 10.1016/j.cell.2009.01.002, 19167326.
14. Shivdasani RA. MicroRNAs: regulators of gene expression and cell differentiation. Blood 2006, 108(12):3646-3653. 10.1182/blood-2006-01-030015, 1895474, 16882713.
15. Zhang BH, Pan XP, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Developmental Biology 2007, 302(1):1-12. 10.1016/j.ydbio.2006.08.028, 16989803.
16. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi J, Natarajan R. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007, 104(9):3432-3437. 10.1073/pnas.0611192104, 1805579, 17360662.
17. Chow TF, Mankaruos M, Scorilas A, Youssef Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, et al. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. J Urol 2010, 183(2):743-751. 10.1016/j.juro.2009.09.086, 20022054.
18. Agrawal R, Tran U, Wessely O. The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1. Development 2009, 136(23):3927-3936. 10.1242/dev.037432, 2778741, 19906860.
19. Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P, et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 2008, 19(11):2159-2169. 10.1681/ASN.2008030312, 2573016, 18776119.
20. Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 2008, 19(11):2069-2075. 10.1681/ASN.2008020162, 2573018, 18832437.
21. Harvey SJ, Jarad G, Cunningham J, Goldberg S, Schermer B, Harfe BD, McManus MT, Benzing T, Miner JH. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol 2008, 19(11):2150-2158. 10.1681/ASN.2008020233, 2573015, 18776121.
22. Lee SO, Masyuk T, Splinter P, Banales JM, Masyuk A, Stroope A, Larusso N. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest 2008, 118(11):3714-3724. 10.1172/JCI34922, 2571032, 18949056.
23. Pandey P, Brors B, Srivastava PK, Bott A, Boehn SN, Groene HJ, Gretz N. Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics 2008, 9:624. 10.1186/1471-2164-9-624, 2640396, 19102782.
24. Tran U, Zakin L, Schweickert A, Agrawal R, Doger R, Blum M, De Robertis EM, Wessely O. The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity. Development 2010, 137(7):1107-1116. 10.1242/dev.046045, 2835326, 20215348.
25. Lu W, Shen X, Pavlova A, Lakkis M, Ward CJ, Pritchard L, Harris PC, Genest DR, Perez-Atayde AR, Zhou J. Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum Mol Genet 2001, 10(21):2385-2396. 10.1093/hmg/10.21.2385, 11689485.
26. Wettenhall JM, Smyth GK. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 2004, 20(18):3705-3706. 10.1093/bioinformatics/bth449, 15297296.
27. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics 2007, 23(2):257-258. 10.1093/bioinformatics/btl567, 17098774.
28. Chen WC, Tzeng YS, Li H. Gene expression in early and progression phases of autosomal dominant polycystic kidney disease. BMC Res Notes 2008, 1:131. 10.1186/1756-0500-1-131, 2632667, 19099603.
29. Song X, Di Giovanni V, He N, Wang K, Ingram A, Rosenblum ND, Pei Y. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 2009, 18(13):2328-2343. 10.1093/hmg/ddp165, 19346236.
30. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Marshall KA, et al. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 2009, 37(Database issue):D885-890. 2686538, 18940857.
31. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120(1):15-20. 10.1016/j.cell.2004.12.035, 15652477.
32. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human microRNA targets (vol 2, pg 1862, 2005). Plos Biology 2005, 3(7):1328-1328.
33. Wang XW, El Naqa IM. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 2008, 24(3):325-332. 10.1093/bioinformatics/btm595, 18048393.
34. Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL, Dalamagas T, Giannopoulos G, Goumas G, Koukis E, Kourtis K, et al. DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Research 2009, 37:W273-W276. 10.1093/nar/gkp292, 2703977, 19406924.
35. Sweeney W, Avner E. Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am J Physiol 1998, 275:F387-F394.
36. Sweeney WE, Chen Y, Nakanishi K, Frost P, ED A. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney International 2000, 57(1):33-40. 10.1046/j.1523-1755.2000.00829.x, 10620185.
37. Kuo NT, Norman JT, PD W. Acidic FGF regulation of hyperproliferation of fibroblasts in human autosomal dominant polycystic kidney disease. Biochem Mol Med 1997, 61(2):178-191. 10.1006/bmme.1997.2583, 9259983.
38. Hollinger S, Hepler JR. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev 2002, 54(3):527-559. 10.1124/pr.54.3.527, 12223533.
39. Yamaguchi T, Hempson SJ, Reif GA, Hedge AM, Wallace DP. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol 2006, 17(1):178-187. 10.1681/ASN.2006080912, 16319189.
40. Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med 2009, 60:321-337. 10.1146/annurev.med.60.101707.125712, 2834200, 18947299.
41. Ong AC, Harris PC. Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int 2005, 67(4):1234-1247. 10.1111/j.1523-1755.2005.00201.x, 15780076.
42. Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, et al. Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease. New England Journal of Medicine 2010, 26(9):820-9. 363.
43. Walz G, Budde K, Mannaa M, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hörl WH, Obermüller N, et al. Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease. New England Journal of Medicine 2010, 363(9):830-840. 10.1056/NEJMoa1003491, 20581392.
44. Petrie K, Guidez F, Howell L, Healy L, Waxman S, Greaves M, Zelent A. The histone deacetylase 9 gene encodes multiple protein isoforms. J Biol Chem 2003, 278(18):16059-16072. 10.1074/jbc.M212935200, 12590135.
45. David D, Cardoso J, Marques B, Marques R, Silva ED, Santos H, Boavida MG. Molecular characterization of a familial translocation implicates disruption of HDAC9 and possible position effect on TGFbeta2 in the pathogenesis of Peters' anomaly. Genomics 2003, 81(5):489-503. 10.1016/S0888-7543(03)00046-6, 12706107.
46. Chuaqui RF, Bonner RF, Best CJM, Gillespie JW, Flaig MJ, Hewitt SM, Phillips JL, Krizman DB, Tangrea MA, Ahram M, et al. Post-analysis follow-up and validation of microarray experiments. Nature Genetics 2002, 32:509-514. 10.1038/ng1034, 12454646.
47. Morey JS, Ryan JC, Dolah FMV. Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online 2006, 8(1):175-193. 10.1251/bpo126, 1779618, 17242735.
48. Saal S, Harvey SJ. MicroRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens 2009, 18(4):317-323. 10.1097/MNH.0b013e32832c9da2, 19424061.
49. Gaj S, Eijssen L, Mensink RP, Evelo CTA. Validating nutrient-related gene expression changes from microarrays using RT2 PCR-arrays. Genes and Nutrition 2008, 3(3-4):153-157. 10.1007/s12263-008-0094-1, 2593020, 19034552.
50. Marshall C. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80:179-185. 10.1016/0092-8674(95)90401-8, 7834738.
51. Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG. A critical development switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nature Medicine 2007, 13(12):1490-1495. 10.1038/nm1675, 2302790, 17965720.
52. Patel V, Li L, Cobo-Stark P, Shao X, Somlo S, Lin F, P I. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum Mol Genet 2008, 17(11):1578-1590. 10.1093/hmg/ddn045, 18263895.
53. Happe H, Leonhard WN, Van der Wal A, Van de Water B, Lantinga-van Leeuwen IS, Breuning MH, De Heer E, DJ P. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol genet 2009, 18(14):2532-2542. 10.1093/hmg/ddp190, 19401297.
54. Koupepidou P, Felekkis KN, Kranzlin B, Sticht C, Gretz N, C D. Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways. BMC Nephrology 2010, 11(23).
55. Saadi-Kheddouci S, Berrebi D, Romagnolo B, Cluzeaud F, Peuchmaur M, Kahn A, Vandewalle A, Perret C. Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene 2001, 20(42):5972-5981. 10.1038/sj.onc.1204825, 11593404.
56. Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney International 2009, 76:149-168. 10.1038/ki.2009.128, 2812475, 19455193.
57. Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. Journal of Cell Sceince 2003, 116:2627-2634.
58. Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A, Aaronson SA. Interaction of Frizzled Related Protein (FRP) with Wnt Ligands and the Frizzled Receptor Suggests Alternative Mechanisms for FRP Inhibition of Wnt Signaling. Journal of Biological Chemistry 1999, 274(23):16180-16187. 10.1074/jbc.274.23.16180, 10347172.
59. Belo JA, Bachiller D, Agius E, Kemp C, Borges AC, Marques S, Piccolo S, de Robertis EM. Cerberus-like is a secreted BMP and nodal antagonist not essential for mouse development. Genesis 2000, 26:265-270. 10.1002/(SICI)1526-968X(200004)26:4<265::AID-GENE80>3.0.CO;2-4, 10748465.
60. Torres VE, Harris PC. Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases. Nature Clinical Practice Nephrology 2007, 2(1):40-55.
61. Imbach T, Grunewald S, Schenk B, Burda P, Schollen E, Wevers RA, Jaeken J, de Klerk JB, Berger EG, Matthijs G, et al. Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic. Hum Genet 2000, 106(5):538-545. 10.1007/s004390050022, 10914684.
62. Charron AJ, Nakamura S, Bacallao R, Wandinger-Ness A. Compromised Cytoarchitecture and Polarized Trafficking in Autosomal Dominant Polycystic Kidney Disease Cells. Journal of Cell Biology 2000, 149(1):111-124. 10.1083/jcb.149.1.111, 2175108, 10747091.
63. Qin S, Taglienti M, Nauli SM, Contrino L, Takakura A, Zhou J, JA K. Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease. Journal of Clinical Investigation 2010, 120(10):3617-3628. 10.1172/JCI41531, 2947217, 20852388.
64. Reiss G, te Heesen S, Zimmerman J, Robbins PW, Aebi M. Isolation of the ALG6 locus of Saccharomyces cerevisiae required for glucosylation in the N-linked glycosylation pathway. Glycobiology 1996, 6(5):493-498. 10.1093/glycob/6.5.493, 8877369.
65. Flynt AS, Lai EC. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nature Reviews Genetics 2008, 9(11):831-842. 10.1038/nrg2455, 2729318, 18852696.
66. Hooten NN, Abdelmohsen K, Gorospe M, Ejiogu N, Zonderman AB, Evans MK. microRNA Expression Patterns Reveal Differential Expression of Target Genes with Age. Plos One 2010, 5(5).
67. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nature Reviews Molecular Cell Biology 2010, 11(4):252-263.
68. Fish JE, Santoro MM, Morton SU, Yu SH, Yeh RF, Wythe JD, Lvey KN, Bruneau BG, Stainier DYR, Srivastava D. MiR-126 regulates angiogenic signaling and vascular integrity. Developmental Cell 2008, 15(2):272-284. 10.1016/j.devcel.2008.07.008, 2604134, 18694566.
69. Jackson RJ, N S. How do microRNAs regulate gene expression?. Sci STKE 2007 2007, 2007(367):re1.
70. Neilson JR, Zheng GX, Burge CB, Sharp PA. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 2007, 21(5):578-589. 10.1101/gad.1522907, 1820899, 17344418.